Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Prolight Diagnostics AB | 8,811,346 | net | 09 Jul 2025 | tx 21+8,811,346 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jul 2025 | PURCHASE | Prolight Diagnostics AB | 349,040 | 0.20 SEK | |
| 30 Jun 2025 | PURCHASE | Prolight Diagnostics AB | 2,400,960 | 0.20 SEK | first after silence |
| 21 Oct 2024 | OTHER | Prolight Diagnostics AB | 350,000 | 0.12 SEK | |
| 21 Oct 2024 | OTHER | Prolight Diagnostics AB | 350,000 | 0.00 SEK | deriv |
| 03 Jun 2024 | OTHER | Prolight Diagnostics AB | 1,200,000 | 0.10 SEK | |
| 03 Jun 2024 | OTHER | Prolight Diagnostics AB | 1,200,000 | 0.00 SEK | deriv |
| 24 May 2024 | PURCHASE | Prolight Diagnostics AB | 500,000 | 0.00 SEK | deriv |
| 18 Dec 2023 | PURCHASE | Prolight Diagnostics AB | 350,000 | 0.70 SEK | |
| 18 Jan 2023 | PURCHASE | Prolight Diagnostics AB | 500,000 | 0.34 SEK | |
| 21 Dec 2022 | PURCHASE | Prolight Diagnostics AB | 68,828 | 0.17 SEK | |
| 30 Aug 2022 | PURCHASE | Prolight Diagnostics AB | 1,000,000 | 0.02 SEK | deriv |
| 23 May 2022 | PURCHASE | Prolight Diagnostics AB | 32,886 | 0.35 SEK | |
| 24 May 2022 | PURCHASE | Prolight Diagnostics AB | 87,314 | 0.36 SEK | |
| 25 May 2022 | PURCHASE | Prolight Diagnostics AB | 42,949 | 0.34 SEK | |
| 27 May 2022 | PURCHASE | Prolight Diagnostics AB | 36,851 | 0.34 SEK | |
| 22 Apr 2022 | PURCHASE | Prolight Diagnostics AB | 115,610 | 0.49 SEK | |
| 21 Apr 2022 | PURCHASE | Prolight Diagnostics AB | 115,941 | 0.48 SEK | |
| 20 Apr 2022 | PURCHASE | Prolight Diagnostics AB | 4,367 | 0.47 SEK | |
| 19 Apr 2022 | PURCHASE | Prolight Diagnostics AB | 90,960 | 0.47 SEK | |
| 14 Apr 2022 | PURCHASE | Prolight Diagnostics AB | 1 | 0.49 SEK | anomaly |
| 13 Apr 2022 | PURCHASE | Prolight Diagnostics AB | 15,639 | 0.46 SEK |
1 purchase reported after at least 12 months of silence — most recent on 30 Jun 2025.